AGEN - アジェナス (Agenus Inc.) アジェナス

 AGENのチャート


 AGENの企業情報

symbol AGEN
会社名 Agenus Inc (アジェナス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アジェナス(Agenus Inc.)は免疫腫瘍学(I-O)会社である。同社は癌と戦うために身体の免疫システムに関わる治療法の発見と開発に従事する。同社は、ヒト抗体を産生するように設計されたレトロサイトディスプレイ、SECANT酵母ディスプレイおよびファージディスプレイ技術を含む抗体発見プラットフォーム、チェックポイントモジュレーター(CPM)プログラムを含む抗体候補プログラム、並びにProphage、AutoSynVax、PhosPhoSynVax及びQS-21スチムロンアジュバント(QS-21スチムロン)を主とするサポニンベースのワクチンアジュバントを含むワクチンプログラムなどのプラットフォームとプログラムによって駆動されるI-Oポートフォリオを開発している。同社の発見パイプラインには、一連のチェックポイント変調(CPM)抗体が含まれる。ワクチンプラットフォームには、その熱ショックタンパク質(HSP)ベースのプロファージワクチン候補、およびその合成ワクチン候補のASVとPSVが含まれる。   アジェナスは米国のバイオ医薬品メ―カ―。主に、がん治療を目的に、免疫システム機能を調節するチェックポイント調節因子を標的とした抗体医薬品の発見、開発、商用化に従事。脳腫瘍、腎臓がん、肺がん、アルツハイマ―などの免疫治療用ワクチンの研究を行う。本社はマサチュ―セッツ州。   Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in Lexington, MA.
本社所在地 3 Forbes Road Lexington MA 02421 USA
代表者氏名 Garo H. Armen ガロ・アーメン
代表者役職名 Chairman of the Board Chief Executive Officer Founder
電話番号 +1 781-674-4410
設立年月日 1994年
市場名 NASDAQ Small Cap
ipoyear 2000年
従業員数 255人
url www.agenusbio.com
nasdaq_url https://www.nasdaq.com/symbol/agen
adr_tso
EBITDA EBITDA(百万ドル) -113.91800
終値(lastsale) 2.07
時価総額(marketcap) 234493980.12
時価総額 時価総額(百万ドル) 223.16580
売上高 売上高(百万ドル) 29.24434
企業価値(EV) 企業価値(EV)(百万ドル) 193.05562
当期純利益 当期純利益(百万ドル) -150.89400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Agenus Inc revenues decreased 44% to $17.5M. Net loss applicable to common stockholders increased 61% to $78.9M. Revenues reflect Revenue (research and development) decrease of 61% to $12.1M. Higher net loss reflects Non-operating income (expense) decrease from $2.4M (income) to $1.4M (expense) GENERAL AND ADMINISTRATIVE increase of 23% to $16.3M (expense).

 AGENのテクニカル分析


 AGENのニュース

   Agenus Inc. (AGEN) Sitting On The Launch Pad, Waiting For Long Term Investors  2022/09/09 14:00:00 Stocks Register
Agenus Inc. (NASDAQ:AGEN) price on Thursday, September 08, rose 3.15% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.62. A look at the stock’s price movement, the close in the last trading session was $2.54, moving within a range at $2.485 and $2.66. The beta value (5-Year … Agenus Inc. (AGEN) Sitting On The Launch Pad, Waiting For Long Term Investors Read More »
   Agenus Inc. Still Hasn’t Convinced Analysts?  2022/09/06 15:30:00 Stocks Register
Agenus Inc. (NASDAQ:AGEN) price closed lower on Friday, September 02, dropping -5.86% below its previous close. A look at the daily price movement shows that the last close reads $2.73, with intraday deals fluctuated between $2.57 and $2.80. The company’s 5Y monthly beta was ticking 1.08 while its P/E ratio in the trailing 12-month period … Agenus Inc. Still Hasn’t Convinced Analysts? Read More »
   Agenus Inc.’s (NASDAQ: AGEN) Stock Price Continues To Fall  2022/08/24 11:00:00 Stocks Register
The trading price of Agenus Inc. (NASDAQ:AGEN) closed higher on Tuesday, August 23, closing at $2.88, 4.35% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $2.765 and $2.93. The company’s P/E ratio in the trailing 12-month period was 25.49, while its 5Y monthly … Agenus Inc.’s (NASDAQ: AGEN) Stock Price Continues To Fall Read More »
   Today’s watch list includes Agenus Inc. (NASDAQ:AGEN) stock  2022/08/22 17:24:00 US Post News
Agenus Inc. (AGEN)’s stock has witnessed a price hike of 0.18% from the previous close with its current price standing at $2.80. Its current price is -58.84% under its 52-week high of $6.79 and 123.60% more than its 52-week low of $1.25. Based on the past 30-day period, the stock price is -10.47% below the […]
   Agenus Inc. (NASDAQ:AGEN) Shares Surges 2.30% In A Week – But Can It Keep Rising?  2022/08/11 11:00:00 Marketing Sentinel
In last trading session, Agenus Inc. (NASDAQ:AGEN) saw 4.74 million shares changing hands with its beta currently measuring 1.19. Company’s recent per share price level of $2.67 trading at $0.11 or 4.30% at ring of the bell on the day assigns it a market valuation of $697.11M. That closing price of AGEN’s stock is at … Agenus Inc. (NASDAQ:AGEN) Shares Surges 2.30% In A Week – But Can It Keep Rising? Read More »
   Agenus Inc. Expected to Post FY2021 Earnings of ($0.27) Per Share (NASDAQ:AGEN)  2021/10/27 12:32:42 Transcript Daily
Agenus Inc. (NASDAQ:AGEN) Research analysts at Jefferies Financial Group boosted their FY2021 EPS estimates for Agenus in a note issued to investors on Monday, October 25th. Jefferies Financial Group analyst K. Shi now forecasts that the biotechnology company will post earnings per share of ($0.27) for the year, up from their previous forecast of []
   Q3 2021 EPS Estimates for Agenus Inc. (NASDAQ:AGEN) Cut by B. Riley  2021/10/27 11:00:56 Dakota Financial News
Agenus Inc. (NASDAQ:AGEN) Stock analysts at B. Riley dropped their Q3 2021 EPS estimates for Agenus in a note issued to investors on Monday, October 25th. B. Riley analyst M. Mamtani now forecasts that the biotechnology company will earn $0.55 per share for the quarter, down from their prior estimate of $0.57. B. Riley []
   Agenus (NASDAQ:AGEN) Stock Price Down 4.2%  2021/10/25 17:42:49 Transcript Daily
Agenus Inc. (NASDAQ:AGEN)s stock price was down 4.2% on Monday . The company traded as low as $3.81 and last traded at $3.84. Approximately 134,549 shares changed hands during trading, a decline of 97% from the average daily volume of 4,077,423 shares. The stock had previously closed at $4.01. A number of analysts recently weighed []
   Medical sectors Agenuss (NASDAQ:AGEN) Buy rating Reiterated by B. Riley  2021/10/25 17:38:00 Stock Market Daily
Agenus (NASDAQ:AGEN)s stock had its Buy rating Reiterated by by analysts at $11.00 in a research report issued to clients and investors. The post Medical sectors Agenuss (NASDAQ:AGEN) Buy rating Reiterated by B. Riley appeared first on .
   Agenus (NASDAQ:AGEN) Stock Rating Reaffirmed by B. Riley  2021/10/25 12:40:41 Dakota Financial News
Agenus (NASDAQ:AGEN)s stock had its buy rating reiterated by analysts at B. Riley in a research report issued to clients and investors on Monday, The Fly reports. They presently have a $11.00 price objective on the biotechnology companys stock, down from their prior price objective of $12.00. B. Rileys price objective points to a potential []
   Agenus to Participate in the Raymond James 2021 Human Health Innovation Conference  2021/06/21 13:00:00 Intrado Digital Media
LEXINGTON, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Jennifer Buell, PhD, President and COO of Agenus, will present at the Raymond James 2021 Human Health Innovation Conference on Tuesday, June 22, 2021 from 8:40 a.m. to 9:10 a.m. ET.
   Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer  2021/06/17 14:23:02 Business Insider Markets
The FDA has accepted for review Agenus Inc''s (NASDAQ: AGEN ) marketing application seeking approval for
   FDA accepts Agenus'' balstilimab BLA under "priority review" status  2021/06/17 12:45:02 Seeking Alpha
   Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN)  2021/06/13 21:10:49 Stock Equity
Agenus Inc. (NASDAQ:AGEN) with the stream of 0.97% also noticed, India Devon Energy Corporation (NYSE:DVN) encountered a rapid change of 0.45% in the last hour of Fridays trading session. Agenus The post Market Mover: Agenus Inc. (NASDAQ:AGEN), Devon Energy Corporation (NYSE:DVN) appeared first on Stocks Equity .
   Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN)  2021/06/07 13:15:17 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Springworks Therapeutics (SWTX) and Agenus The post Analysts Top Healthcare Picks: Springworks Therapeutics (SWTX), Agenus (AGEN) appeared first on Smarter Analyst .

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アジェナス AGEN Agenus Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)